Clinical trials
Active, not recruiting Melanoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma Institute Australia | 4 |
| Bristol-Myers Squibb | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Regeneron Pharmaceuticals | 3 |
| Erasca, Inc. | 2 |
| Genentech, Inc. | 2 |
| Melanoma and Skin Cancer Trials Limited | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 41 |
| Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Carcinoma, Renal Cell | 6 |
| Colorectal Neoplasms | 5 |
| Skin Neoplasms | 5 |
| Brain Neoplasms | 4 |
| Carcinoma, Transitional Cell | 4 |
| Pancreatic Neoplasms | 4 |
| Breast Neoplasms | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.